ArticleBMC medical informatics and decision making2025
Development and validation of an artificial intelligence-based model for cardiovascular disease prediction using longitudinal data.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Per- and Polyfluoroalkyl Substances Exposure and Ischemic Heart Disease: Emerging Evidence from the Literature.Antioxidants (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis research uses machine learning (ML) models to determine significant predictive factors for CVD events in Iran, a country with high mortality rates. The study evaluates the effectiveness of deep learning and mixed-effects logistic models in predicting 10-year CVD incidence using longitudinal TLGS data.
methodsA total of 4,872 adults aged ≥ 30 years without a history of CVD at baseline (2006-2008) were followed until 2020. Following exclusions due to prevalent CVD or insufficient follow-up data, the final analytic sample comprised 1,942 men and 2,930 women. Baseline demographic, behavioral, and biochemical characteristics were utilized as input features. A clinical history examination was employed to identify and confirm incident CVD events, such as stroke and coronary heart disease (CHD). Using longitudinal data collected during a 10-year study period, deep learning models based on Long Short-Term Memory (LSTM) and Gated Recurrent Unit (GRU) architectures were utilized to detect variations in risk factor dynamics. The area under the receiver operating characteristic curve (AUC) was employed to assess the model's performance.
resultsDuring the follow-up period, 545 participants (11.2%) experienced CVD events. In both sexes, the GRU model outperformed the LSTM model. In women, the GRU achieved an AUC of 0.739, whereas in men it achieved 0.738, in both cases outperforming LSTM. Compared with the traditional mixed-effects model, discrimination was comparable in women (GRU 0.739 vs. 0.74) and higher in men (0.738 vs. 0.70). Even though the models were restricted to 21 commonly employed clinical variables, their performance was similar to that of larger-scale studies that included hundreds of variables.
conclusionsDeep learning models, such as GRU, can effectively leverage longitudinal medical data to predict future cardiovascular disease events. The models achieved performance comparable to studies that used far more variables, despite relying on a limited feature set.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.